Esperion Therapeutics





Ebitda Cambio Fecha
AbbVie USD 3.52B 828M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Cipla INR 12.55B 6.4B 2025-12
CSL USD 3.13B 1.17B 2025-12
Cytokinetics USD -277.18M 169.36M 2025-09
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Geron USD -9.47M 1.92M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12


Esperion Therapeutics - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.